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In Memoriam
Aniru Conteh
1942–2004
On the Front Lines 
of Lassa Fever
A
niru Conteh spent 25 years in his
native Sierra Leone dedicated to
treating patients with Lassa fever, a
rodentborne viral disease, to which he
ultimately succumbed on April 4,
2004. Dr. Conteh’s life is a model of
the dedicated healthcare worker. His
colleagues hope that his death can gal-
vanize support for healthcare workers
and scientists working on the front
lines with Lassa fever virus and other
emerging pathogens. 
The son of the local chief, Aniru
Sahib Sahib Conteh was born in the
small village of Jawi Folu in Eastern
Province, Sierra Leone, in 1942.
When Conteh was 16 years of age, his
mother died, and he left school to help
support the family in the capitol,
Freetown. He eventually returned to
school, where he studied chemistry
and biology, and earned his bachelor’s
degree from Durham University,
Freetown. After working briefly as a
teacher, he enrolled in medical school
at the University of Ibadan, Nigeria.
He graduated in 1974 and stayed on to
work at Ibadan Teaching Hospital. In
1979, Dr. Conteh returned to Sierra
Leone, beginning what would be a 25-
year career dedicated principally to
the fight against Lassa fever. 
Lassa fever was first recognized in
1969 after three nurses working at a
mission hospital in North-Eastern
State, Nigeria, came down with a
mysterious illness (1,2). A new virus
was subsequently isolated from a
blood specimen sent to the Yale
Arbovirus Research Unit and named
Lassa after the village of origin of the
first case-patient (3). A larger out-
break, 28 cases with at least 14 deaths,
occurred in the same region in 1970
(4). Lassa fever was first identified in
Sierra Leone in 1972 in a series of
nosocomial outbreaks (5,6). The dis-
ease was found to be common in the
community as well, constituting a
major cause of illness and death in
eastern Sierra Leone, which prompted
the Centers for Disease Control
(CDC) to establish a Lassa fever
research and control program in
Sierra Leone in 1976 (7).
Dr. Conteh willingly plunged into
this hotbed of Lassa fever in 1979
when he took a post at Nixon
Methodist Hospital in the eastern
town of Segbwema, the central hospi-
tal of CDC’s program. He was named
Nixon Hospital’s medical superinten-
dent in 1980 and later served as the
clinical director of the Lassa fever
treatment ward . When civil war
broke out in 1991, the treatment ward
was moved to the relative safety of
nearby Kenema Government
Hospital, and Dr. Conteh continued as
its director. The war eventually forced
the CDC program to close, but Dr.
Conteh and the Lassa fever ward car-
ried on through the support of the
British medical relief agency, Merlin. 
From 1979 to 2004, Dr. Conteh
treated thousands of patients with
Lassa fever, becoming the unparal-
leled world’s expert on the manage-
ment of the disease, as well as con-
tributing to research on the subject
(8). He persevered despite many
risks—outbreaks of Lassa fever, rebel
invasions, and government counterat-
tacks. Through various projects and
experts, war and peace, and waves of
refugees, Dr. Conteh stayed, continu-
ing to treat patients in his characteris-
tically calm and modest manner. His
dedication, skill, and courage were
some of the few constants in the
unstable and often dangerous world
around him. 
In March 2004, Dr. Conteh admit-
ted a young, pregnant woman to the
Lassa ward with a presumptive diag-
nosis of severe Lassa fever. The
patient was a volunteer nurse on the
hospital’s pediatric service. On March
17, after numerous unsuccessful
attempts by staff members to obtain
blood from the patient’s arm, Dr.
Conteh attempted femoral venipunc-
ture and sustained a needlestick injury
in the process. The patient died the
next day. On March 23, fever devel-
oped in Dr. Conteh. Despite the
administration of intravenous rib-
avirin, profuse vomiting and diarrhea
developed a few days later; these led
to hypovolemic shock and cardiac
arrest, which necessitated resuscita-
tion. Bleeding and renal failure
ensued. Consultations were sought
and received from medical experts
around the world. The diagnosis of
Lassa fever was confirmed from spec-
imens sent to the National Institute for
Communicable Diseases in South
Africa. On April 4, in the cruelest
irony, Aniru Conteh died of a virus
that he had been combating as a
physician for most of his life, a patient
in a ward that he had been instrumen-
tal in establishing and maintaining. 
Dr. Conteh’s death represents more
than a personal loss. His absence
severely undermines the ability to
combat Lassa fever, which remains a
serious threat. Research over the years
has shown that Lassa fever is endem-
ic in Liberia, Guinea, Nigeria, and
Senegal as well, and Lassa virus is
now believed to infect tens of thou-
sands of people and cause thousands
of deaths yearly across West Africa
(7,9–13).
What lessons can we learn? What
response can we have to this tragedy?
We have made progress in our global
response to emerging pathogens, but
many challenges remain. Perhaps the
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most important response is to offer a
sound base of support for combating
emerging diseases where they start,
relying less on the rapid influx of
international experts and the long-dis-
tance shipping of specimens and more
on “home grown” talent, equipped
with the tools and training that they
need. Achieving these goals will be
difficult. Beyond supplying medicine
and laboratory equipment, tackling the
problem will require addressing such
complex issues as low salaries and
“brain drain,” civil unrest, corruption,
and human rights. Dr. Conteh was
exceptional because he persisted in the
face of these challenges, but we can-
not routinely depend on such heroes.
Governments in developing countries,
with international support, need to
build the base to create stable job and
training opportunities, adequate physi-
cal infrastructure, and safe working
environments to foster the develop-
ment of local expertise and encourage
local physicians and scientists to help
fill the role vacated by Dr. Conteh.
Ultimately, containing emerging dis-
eases depends on the Aniru Contehs of
the world. The more support we pro-
vide to people on the front lines, the
healthier and safer we all will be.
Aniru Conteh is survived by his
wife, Sarah, three sons, and two
daughters.
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Correction, vol. 10, no. 9
In “SARS-CoVAntibody Prevalence in All Hong Kong
Patient Contacts” by Gabriel M. Leung et al., errors
occurred on p. 1654. The seventh sentence read “those who
declined testing” but should have been “those who consent-
ed to testing.” 
The corrected sentence reads as follows: However,
those who consented to testing were more likely to report
more frequent contact and closer relationships with SARS
patients, more febrile or respiratory illness episodes since
February, and a travel history to SARS-affected regions,
which may have biased our seroprevalence estimate
upwards.
The corrected article appears online at http://www.cdc.
gov/ncidod/EID/vol10no9/02-0155.htm
We regret any confusion these errors may have caused.